Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Nasal Naloxone Pilot
NCT01939444Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Aug 2013
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of naloxone in opioid overdose (2 arms), sponsored by Norwegian University of Science and Technology. Primary endpoint: Preliminary Bioavailability of Nasal Naloxone at 2 weeks. Started Aug 2013; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT01939444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939444.